Ondine Biomedical Launches ABC Medical Center Pilot of Steriwave® Nasal Photodisinfection  Ondine Biomedical Inc. (AIM: OBI) announces the American British Cowdray (“ABC”) Medical Center in Mexico City will begin piloting Steriwave® nasal photodisinfection system in September. This marks the first hospital deployment of Steriwave in Mexico and will target [...]

Former Mexican President to Chair ‘Light Against AMR Initiative’ to Accelerate Photodisinfection Adoption in High-Growth Regions Ondine Biomedical Inc. (AIM: OBI), a global innovator in antimicrobial photodynamic therapy (APDT, also known as photodisinfection), and the International Photodynamic Association (“IPA”) have launched a strategic initiative to accelerate the deployment of [...]

UK Decision to Cancel Fleming Fund Increases Urgency for Innovative Antimicrobial Solutions; Ondine Biomedical Poised to Lead Fight Against Superbugs The UK government’s decision to cancel the Fleming Fund — a cornerstone initiative in the global fight against antimicrobial resistance (AMR) — comes at a time when new projections [...]

Groundbreaking ICU Study completed Using Steriwave® Nasal Photodisinfection Technology at Royal Columbian Hospital Canada’s Royal Columbian Hospital (British Columbia, Canada) completes a 291-patient pilot study in the intensive care unit (ICU) - world’s first use of nasal photodisinfection in the ICU. ICU patients experience the highest rates of hospital-acquired [...]

Growing Use of Steriwave Across Surgery Types Ondine Biomedical Inc. reports increasing clinical adoption of its light-activated antimicrobial therapy, Steriwave®, across a broad range of surgical specialities in hospitals throughout the UK and Canada to reduce surgical site infections (SSIs). Hospitals are now routinely implementing Steriwave nasal decolonisation prior [...]